
SMS Pharmaceuticals Ltd. (SMSPHARMA): SMS Pharmaceuticals Share Price Rising Today; Stock Gains 9.69%
Updated: 11 Sept 2026 • 10:26 am
Posted by:

SMS Pharmaceuticals Share Price is in focus after the stock rose 9.69% to Rs 459.75 from Rs 419.15, with market capitalisation at Rs 3,815.38 Cr. The move has placed SMS Pharmaceuticals Ltd. among the stocks in news in the Indian stock market today. Latest Univest data confirms the price event, but it does not establish a company-specific catalyst, so the attention is coming from the share price rise itself and the way the market is pricing the company right now.
As of 11 September 2026 at 10:22:54 AM IST, the stock opened at Rs 412.55, touched a high of Rs 466.85 and a low of Rs 412.55. That price action matters because SMS Pharmaceuticals Share Price Today has moved well above the previous close and is trading near the top of the day’s range. For investors following SMS Pharmaceuticals Stock News, the key question is not only why it is rising today, but also how the current valuation, sector context and business metrics frame the move. Univest analysis below keeps the focus on verified market data and measurable fundamentals.
SMS Pharmaceuticals Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 459.75 |
| Previous Close | Rs 419.15 |
| Today's Move | Rs 40.6 (+9.69%) |
| Open | Rs 412.55 |
| High | Rs 466.85 |
| Low | Rs 412.55 |
| Turnover | Rs 9.18 crore |
| Market Capitalisation | Rs 3,815.38 crore |
| Market Cap Category | Small Cap |
SMS Pharmaceuticals Ltd. (SMSPHARMA) rose to Rs 459.75 from the previous close of Rs 419.15, a move of Rs 40.6 or 9.69%. The stock opened at Rs 412.55, reached a high of Rs 466.85, recorded a low of Rs 412.55.
SMS Pharmaceuticals Share Price Today showed a strong intraday gain of Rs 40.60, or 9.69%, to Rs 459.75. The move came after an opening at Rs 412.55, which matched the day’s low, and the stock reached Rs 466.85 during the session. That placed SMS Pharmaceuticals Share Price near the upper end of the trading band, signalling firm buying interest in the share price rise. Turnover stood at Rs 9.18 Cr, which gives a sense of the day’s trading activity without adding any unsupported explanation. For SMS Pharmaceuticals Share Price Live watchers, the market has clearly re-rated the stock higher today, even though the exact company-specific trigger remains unconfirmed in the verified data.
SMS Pharmaceuticals Ltd. (SMSPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 3,815.38 crore |
| P/E Ratio | 38.33x |
| P/B Ratio | 4.87x |
| ROE | 11.91% |
| ROCE | 12.55% |
| EPS | Rs 10.93 |
| Book Value Per Share | Rs 86.06 |
| Dividend Yield | 0.1% |
SMS Pharmaceuticals Ltd. (SMSPHARMA) fundamental metrics show P/E 38.33x, P/B 4.87x, ROE 11.91%, ROCE 12.55%. These figures provide context only and are not a buy or sell signal.
SMS Pharmaceuticals Ltd. has a market capitalisation of Rs 3815.38 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 38.33x, P/B at 4.87x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.91% and ROCE of 12.55%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 10.93, book value per share of Rs 86.06, dividend yield of 0.1%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.73x, median ROE of 11.83%, median ROCE of 13.68%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 38.33x |
| Benchmark Median P/E | 32.73x |
| Benchmark Average P/E | 49.1x |
| Benchmark P/E Range | 3.4x to 701.57x |
| Company P/B Ratio | 4.87x |
| Benchmark Median P/B | 3.06x |
| Company ROE | 11.91% |
| Benchmark Median ROE | 11.83% |
| Company ROCE | 12.55% |
| Benchmark Median ROCE | 13.68% |
| Company Market Capitalisation | Rs 3,815.38 crore |
| Benchmark Median Market Cap | Rs 750.93 crore |
SMS Pharmaceuticals Ltd. (SMSPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
SMS Pharmaceuticals Ltd. (SMSPHARMA) has a P/E ratio of 38.33x, which is above the benchmark median of 32.73x, a difference of +17.11%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
SMS Pharmaceuticals Ltd. (SMSPHARMA) has a ROE of 11.91%, which is above the benchmark median of 11.83%, a difference of +0.68%. SMS Pharmaceuticals Ltd. (SMSPHARMA) has a ROCE of 12.55%, which is below the benchmark median of 13.68%, a difference of -8.26%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,48,315.74 | 36.98 | 5.17 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,51,737.22 | 85.36 | 14.14 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,87,593.62 | 85.95 | 20.89 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,12,618.18 | 24.71 | 4.14 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,10,515.04 | 33.08 | 3.17 | 11.83 | 16 |
SMS Pharmaceuticals Ltd. (SMSPHARMA) has a P/E ratio of 38.33x compared with the displayed peer median of 36.98x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.91% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 12.55% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. SMS Pharmaceuticals Ltd. (SMSPHARMA) has a market capitalisation of Rs 3,815.38 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching SMS Pharmaceuticals
- SMS Pharmaceuticals Share Price rose 9.69% to Rs 459.75, making it one of the day’s notable movers in Healthcare.
- The stock traded between Rs 412.55 and Rs 466.85, which keeps SMS Pharmaceuticals Share Price Today close to the day’s high.
- P/E of 38.33 and P/B of 4.87 keep valuation in focus for SMS Pharmaceuticals Stock News readers.
- ROE of 11.91 and ROCE of 12.55 provide a useful profitability frame for SMS Pharmaceuticals Fundamental Analysis.
- The company’s Rs 3,815.38 Cr market cap and Rs 9.18 Cr turnover make the share price update relevant to market watchers.
About SMS Pharmaceuticals
SMS Pharmaceuticals Ltd. operates in the Pharmaceuticals & Drugs industry within Healthcare. The company is followed on both NSE and BSE, and its business is assessed through standard stock-market lenses such as market capitalisation, valuation ratios and return metrics. In simple terms, SMS Pharmaceuticals Share Price reflects how investors value its present earnings base, book value and position in the pharma segment.
With EPS at Rs 10.93 and book value at Rs 86.06, the company has measurable financial anchors that help explain why SMS Pharmaceuticals Stock News often attracts attention beyond just a day’s move. Dividend yield of 0.1% adds a small income component to the story, while the current market cap places it well above the typical industry median. For readers using Univest, the stock sits in a sector where pricing, returns and peer positioning tend to matter as much as headline movement.
Frequently Asked Questions
Why is SMS Pharmaceuticals Share Price rising today?
Ans. SMS Pharmaceuticals Share Price is rising today because the stock gained 9.69% to Rs 459.75. The latest Univest figures confirm the move, but they do not establish a company-specific catalyst behind the share price rise.
What is SMS Pharmaceuticals Share Price Today?
Ans. SMS Pharmaceuticals Share Price Today is Rs 459.75. It is higher than the previous close of Rs 419.15 and has turned the stock into a notable mover in Healthcare on the Indian stock market today.
How much did SMS Pharmaceuticals stock gain today?
Ans. SMS Pharmaceuticals stock gained Rs 40.60, or 9.69%, from the previous close. That makes SMS Pharmaceuticals Share Price one of the stronger intraday movers among stocks in news right now.
What is the market capitalisation of SMS Pharmaceuticals?
Ans. SMS Pharmaceuticals has a market capitalisation of Rs 3,815.38 Cr. That places SMS Pharmaceuticals Share Price well above the same-industry median market cap of Rs 750.93 Cr. The company operates in the Healthcare sector.
How does SMS Pharmaceuticals look on valuation?
Ans. SMS Pharmaceuticals trades at a P/E of 38.33 and a P/B of 4.87. Both are above the industry medians, so SMS Pharmaceuticals Share Price is not trading at a low valuation versus the benchmark set.
What do EPS, book value and dividend yield show for SMS Pharmaceuticals?
How do ROE and ROCE compare for SMS Pharmaceuticals?
Ans. ROE is 11.91 and ROCE is 12.55. ROE is slightly above the industry median, while ROCE is below it, giving SMS Pharmaceuticals Share Price a mixed efficiency picture in the sector context.
Should investors track SMS Pharmaceuticals on Univest?
Ans. Investors can track SMS Pharmaceuticals Share Price on Univest for live price updates, valuation ratios, market cap, company overview and sector comparisons. It is a useful way to monitor today’s rise alongside broader pharma market context.
Track SMS Pharmaceuticals Share Price on Univest
Use SMS Pharmaceuticals Ltd. (SMSPHARMA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Investors tracking SMS Pharmaceuticals Share Price can use Univest to follow the live share price, share price update, market cap, valuation ratios, company overview and sector comparison in one place. The platform also helps readers review SMS Pharmaceuticals Share Price Live, SMS Pharmaceuticals Latest News and SMS Pharmaceuticals Stock Analysis without switching between market pages. Univest keeps the focus on verified stock-market context, making it easier to track how SMS Pharmaceuticals Share Price Today evolves alongside broader Healthcare and pharma developments.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Recent Articles

US Fed Rate Hike: American Inflation Heats Up, Impact on Indian Equity, Rupee and Gold
16 October 2026

31% Rally in 2 Weeks: Orient Electric Stock Jumps Post Q2
16 October 2026

Tech Mahindra Dividend, Bonus Share 2026: Should You Buy Ahead of Record Date?
16 October 2026

Ambani Taps Massive Reliance Workforce to Boost Jio's Record IPO
16 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
US Fed Rate Hike: American Inflation Heats Up, Impact on Indian Equity, Rupee and Gold
31% Rally in 2 Weeks: Orient Electric Stock Jumps Post Q2
Tech Mahindra Dividend, Bonus Share 2026: Should You Buy Ahead of Record Date?
Ambani Taps Massive Reliance Workforce to Boost Jio's Record IPO
RM Drip and Sprinklers System Ltd. Hits Upper Circuit on NSE, 16 October 2026

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





